The Company’s 7.75% Senior Subordinated Notes due 2020, 3.75% Convertible Senior Subordinated Notes due 2025, 3.75% Convertible Senior Subordinated Notes due 2042 and the 3.50% Convertible Senior Subordinated Notes, due 2044 are fully and unconditionally guaranteed, subject to certain customary release provisions, on an unsecured, joint and several basis by certain wholly-owned subsidiaries of the Company (the “Guarantor Subsidiaries”). The following condensed consolidating unaudited financial data illustrates the composition of Omnicare, Inc. (“Parent”), the Guarantor Subsidiaries and the non-guarantor Subsidiaries as of September 30, 2013 and December 31, 2012 for the balance sheets, as well as the three and nine months ended September 30, 2013 and 2012 for the statements of comprehensive income (loss) and the statements of cash flows for the nine months ended September 30, 2013 and 2012. Management believes separate complete financial statements of the Guarantor Subsidiaries would not provide information that would be necessary for evaluating the sufficiency of the Guarantor Subsidiaries, and thus are not presented. The equity method has been used with respect to the Parent company’s investment in subsidiaries. No consolidating/eliminating adjustment column is presented for the condensed consolidating statements of cash flows since there were no significant consolidating/eliminating adjustment amounts during the periods presented.

Summary Consolidating

Statements of Comprehensive Income (Loss)

(in thousands)



	For the three months ended September 30,
2013:	Parent			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating / Eliminating Adjustments			Omnicare, Inc. and Subsidiaries
Net sales	$	—		$	1,550,628		$	30,373		$	—		$	1,581,001
Cost of sales	—			1,193,518			17,665			—			1,211,183
Gross profit	—			357,110			12,708			—			369,818
Selling, general and administrative expenses	1,504			189,532			4,346			—			195,382
Provision for doubtful accounts	—			24,699			478			—			25,177
Settlement, litigation and other related charges	—			143,484			—			—			143,484
Other charges	—			54,361			7,271			—			61,632
Operating income (loss)	(1,504		)	(54,966		)	613			—			(55,857		)
Interest expense, net of investment income	(34,583		)	(341		)	2			—			(34,922		)
Income (loss) before income taxes	(36,087		)	(55,307		)	615			—			(90,779		)
Income tax (benefit) expense	(14,190		)	(13,390		)	3,110			—			(24,470		)
Equity of net income of subsidiaries	(44,412		)	—			—			44,412			—
Net income (loss)	$	(66,309	)	$	(41,917	)	$	(2,495	)	$	44,412		$	(66,309	)
Comprehensive income (loss)	$	(66,305	)	$	(41,917	)	$	(2,495	)	$	44,412		$	(66,305	)
2012:
Net sales	$	—		$	1,467,240		$	34,108		$	—		$	1,501,348
Cost of sales	—			1,108,650			21,403			—			1,130,053
Gross profit	—			358,590			12,705			—			371,295
Selling, general and administrative expenses	988			196,993			5,569			—			203,550
Provision for doubtful accounts	—			23,591			456			—			24,047
Settlement, litigation and other related charges	—			4,931			—			—			4,931
Other charges	—			14,951			(9,915		)	—			5,036
Operating income (loss)	(988		)	118,124			16,595			—			133,731
Interest expense, net of investment income	(37,625		)	(1,359		)	(52		)	—			(39,036		)
Income (loss) before income taxes	(38,613		)	116,765			16,543			—			94,695
Income tax (benefit) expense	(15,116		)	45,717			2,669			—			33,270
Equity of net income of subsidiaries	84,922			—			—			(84,922		)	—
Net income	$	61,425		$	71,048		$	13,874		$	(84,922	)	$	61,425
Comprehensive income	$	63,354		$	71,048		$	15,801		$	(86,849	)	$	63,354

Note 9 - Guarantor Subsidiaries (Continued)

Summary Consolidating

Statements of Comprehensive Income (Loss)

(in thousands)



	For the nine months ended September 30,
2013:	Parent			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating / Eliminating Adjustments			Omnicare, Inc. and Subsidiaries
Net sales	$	—		$	4,579,718		$	96,183		$	—		$	4,675,901
Cost of sales	—			3,501,068			55,741			—			3,556,809
Gross profit	—			1,078,650			40,442			—			1,119,092
Selling, general and administrative expenses	3,696			582,512			14,688			—			600,896
Provision for doubtful accounts	—			73,301			1,448			—			74,749
Settlement, litigation and other related charges	—			169,615			—			—			169,615
Other charges	—			89,635			7,271			—			96,906
Operating income (loss)	(3,696		)	163,587			17,035			—			176,926
Interest expense, net of investment income	(92,757		)	(884		)	(364		)	—			(94,005		)
Income (loss) before income taxes	(96,453		)	162,703			16,671			—			82,921
Income tax (benefit) expense	(37,395		)	70,770			9,282			—			42,657
Equity of net income of subsidiaries	99,322			—			—			(99,322		)	—
Net income	$	40,264		$	91,933		$	7,389		$	(99,322	)	$	40,264
Comprehensive income	$	40,170		$	91,933		$	7,389		$	(99,322	)	$	40,170
2012:
Net sales	$	—		$	4,525,967		$	104,476		$	—		$	4,630,443
Cost of sales	—			3,456,366			67,336			—			3,523,702
Gross profit	—			1,069,601			37,140			—			1,106,741
Selling, general and administrative expenses	3,110			586,237			16,205			—			605,552
Provision for doubtful accounts	—			71,176			1,380			—			72,556
Settlement, litigation and other related charges	—			38,227			—			—			38,227
Other charges	35,092			34,677			(4,012		)	—			65,757
Operating income (loss)	(38,202		)	339,284			23,567			—			324,649
Interest expense, net of investment income	(103,146		)	(1,897		)	(401		)	—			(105,444		)
Income (loss) from continuing operations before income taxes	(141,348		)	337,387			23,166			—			219,205
Income tax (benefit) expense	(54,772		)	130,624			7,497			—			83,349
Equity of net income of subsidiaries	222,432			—			—			(222,432		)	—
Net income	$	135,856		$	206,763		$	15,669		$	(222,432	)	$	135,856
Comprehensive income	$	136,518		$	206,763		$	17,053		$	(223,816	)	$	136,518

Note 9 - Guarantor Subsidiaries (Continued)

Condensed Consolidating Balance Sheets

(in thousands)



As of September 30, 2013:	Parent		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Consolidating/Eliminating Adjustments			Omnicare, Inc. and Subsidiaries
ASSETS
Cash and cash equivalents	$	428,003	$	64,975	$	12,709	$	—		$	505,687
Restricted cash	—		5		—		—			5
Accounts receivable, net (including intercompany)	—		736,423		312,572		(307,942		)	741,053
Inventories	—		414,238		7,561		—			421,799
Deferred income tax benefits, net-current	—		98,294		—		(205		)	98,089
Other current assets	2,683		287,807		21,736		—			312,226
Total current assets	430,686		1,601,742		354,578		(308,147		)	2,078,859
Properties and equipment, net	—		305,542		4,683		—			310,225
Goodwill	—		4,224,637		28,824		—			4,253,461
Identifiable intangible assets, net	—		163,718		2,387		—			166,105
Other noncurrent assets	47,654		59,200		22		—			106,876
Investment in subsidiaries	5,194,188		—		—		(5,194,188		)	—
Total assets	$	5,672,528	$	6,354,839	$	390,494	$	(5,502,335	)	$	6,915,526
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities	$	584,220	$	820,997	$	26,725	$	(307,942	)	$	1,124,000
Long-term debt, notes and convertible debentures	1,411,458		15,014		—		—			1,426,472
Deferred income tax liabilities	350,629		617,369		15,207		(205		)	983,000
Other noncurrent liabilities	—		54,183		1,650		—			55,833
Stockholders' equity	3,326,221		4,847,276		346,912		(5,194,188		)	3,326,221
Total liabilities and stockholders' equity	$	5,672,528	$	6,354,839	$	390,494	$	(5,502,335	)	$	6,915,526
As of December 31, 2012:
ASSETS
Cash and cash equivalents	$	383,674	$	58,312	$	12,227	$	—		$	454,213
Restricted cash	—		1,066		—		—			1,066
Accounts receivable, net (including intercompany)	—		849,753		197,370		(190,071		)	857,052
Inventories	—		379,448		6,250		—			385,698
Deferred income tax benefits, net-current	—		137,736		—		(1,550		)	136,186
Other current assets	1,765		248,833		14,871		(10,825		)	254,644
Total current assets	385,439		1,675,148		230,718		(202,446		)	2,088,859
Properties and equipment, net	—		276,056		6,604		—			282,660
Goodwill	—		4,219,900		37,059		—			4,256,959
Identifiable intangible assets, net	—		193,852		3,021		—			196,873
Other noncurrent assets	75,336		93,508		11,382		(16,313		)	163,913
Investment in subsidiaries	5,453,702		—		—		(5,453,702		)	—
Total assets	$	5,914,477	$	6,458,464	$	288,784	$	(5,672,461	)	$	6,989,264

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities	$	60,454	$	587,025	$	35,431	$	(200,896	)	$	482,014
Long-term debt, notes and convertible debentures	2,012,807		17,223		5,000		(5,000		)	2,030,030
Deferred income tax liabilities	335,504		559,405		21,301		(1,550		)	914,660
Other noncurrent liabilities	—		68,161		—		(11,313		)	56,848
Stockholders' equity	3,505,712		5,226,650		227,052		(5,453,702		)	3,505,712
Total liabilities and stockholders' equity	$	5,914,477	$	6,458,464	$	288,784	$	(5,672,461	)	$	6,989,264

Note 9 - Guarantor Subsidiaries (Continued)

Condensed Consolidating Statements of Cash Flows

(in thousands)



	Nine months ended September 30,
2013:	Parent			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Omnicare, Inc. and Subsidiaries
Cash flows from operating activities:
Net cash flows (used in) from operating activities	$	(42,519	)	$	505,815		$	(8,631	)	$	454,665
Cash flows from investing activities:
Acquisition of businesses, net of cash received	—			(3,798		)	—			(3,798		)
Divestiture of businesses, net	—			675			10,408			11,083
Capital expenditures	—			(72,832		)	(1,295		)	(74,127		)
Other	(227		)	668			—			441
Net cash flows (used in) from investing activities	(227		)	(75,287		)	9,113			(66,401		)
Cash flows from financing activities:
Payments on terms loans	(15,938		)	—			—			(15,938		)
Payments on long-term borrowings and obligations	(190,403		)	—			—			(190,403		)
Fees paid for financing activities	(4,851		)	—			—			(4,851		)
Decrease in cash overdraft balance	(10,232		)	(1,258		)	—			(11,490		)
Payments for Omnicare common stock repurchase	(91,259		)	—			—			(91,259		)
Dividends paid	(43,011		)	—			—			(43,011		)
Other	442,769			(422,607		)	—			20,162
Net cash flows from (used in) financing activities	87,075			(423,865		)	—			(336,790		)
Net increase in cash and cash equivalents	44,329			6,663			482			51,474
Cash and cash equivalents at beginning of period	383,674			58,312			12,227			454,213
Cash and cash equivalents at end of period	$	428,003		$	64,975		$	12,709		$	505,687
2012:
Cash flows from operating activities:
Net cash flows (used in) from operating activities	$	(43,685	)	$	457,344		$	3,244		$	416,903
Cash flows from investing activities:
Acquisition of businesses, net of cash received	—			(34,411		)	—			(34,411		)
Divestiture of business, net	—			19,207			—			19,207
Marketable Securities	(25,000		)	—			—			(25,000		)
Capital expenditures	—			(69,486		)	(1,947		)	(71,433		)
Other	—			850			498			1,348
Net cash flows used in investing activities	(25,000		)	(83,840		)	(1,449		)	(110,289		)
Cash flows from financing activities:
Payments on term loans	(19,375		)	—			—			(19,375		)
Proceeds from long-term borrowings and obligations	425,000			—			—			425,000
Payments on long-term borrowings and obligations	(452,302		)	—			—			(452,302		)
Capped call transaction	(48,126		)	—			—			(48,126		)
Payments for Omnicare common stock repurchases	(110,919		)	—			—			(110,919		)
Dividends paid	(30,765		)	—			—			(30,765		)
Other	396,155			(398,374		)	(762		)	(2,981		)
Net cash flows from (used in) financing activities	159,668			(398,374		)	(762		)	(239,468		)
Net increase (decrease) in cash and cash equivalents	90,983			(24,870		)	1,033			67,146
Cash and cash equivalents at beginning of period	460,253			101,786			18,223			580,262
Cash and cash equivalents at end of period	$	551,236		$	76,916		$	19,256		$	647,408

Note 9 - Guarantor Subsidiaries (Continued)

The Company’s 3.25% convertible senior debentures due 2035 (with optional redemption by Omnicare on or after, or an optional repurchase right of holders on, December 15, 2015, at par) are fully and unconditionally guaranteed, subject to certain customary release provisions, on an unsecured basis by Omnicare Purchasing Company, LP, a wholly-owned subsidiary of the Company (the “Guarantor Subsidiary”). The following condensed consolidating unaudited financial data illustrates the composition of Omnicare, Inc. (“Parent”), the Guarantor Subsidiary and the non-guarantor Subsidiaries as of September 30, 2013 and December 31, 2012 for the balance sheets, as well as the three and nine months ended September 30, 2013 and 2012 for the statements of comprehensive income (loss) and the statements of cash flows for the nine months ended September 30, 2013 and 2012. Management believes separate complete financial statements of the Guarantor Subsidiary would not provide information that would be necessary for evaluating the sufficiency of the Guarantor Subsidiary, and thus are not presented. The Guarantor Subsidiary does not have any material net cash flows in the condensed consolidating statements of cash flows. The equity method has been used with respect to the Parent company’s investment in subsidiaries. No consolidating/eliminating adjustments column is presented for the condensed consolidating statements of cash flows since there were no significant consolidating/eliminating adjustment amounts during the periods presented.

Summary Consolidating

Statements of Comprehensive Income (Loss)

(in thousands)



	For the three months ended September 30,
2013:	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries			Consolidating / Eliminating Adjustments			Omnicare, Inc. and Subsidiaries
Net sales	$	—		$	—		$	1,581,001		$	—		$	1,581,001
Cost of sales	—			—			1,211,183			—			1,211,183
Gross profit	—			—			369,818			—			369,818
Selling, general and administrative expenses	1,504			417			193,461			—			195,382
Provision for doubtful accounts	—			—			25,177			—			25,177
Settlement, litigation and other related charges	—			—			143,484			—			143,484
Other charges	—			—			61,632			—			61,632
Operating income (loss)	(1,504		)	(417		)	(53,936		)	—			(55,857		)
Interest expense, net of investment income	(34,583		)	—			(339		)	—			(34,922		)
Income (loss) before income taxes	(36,087		)	(417		)	(54,275		)	—			(90,779		)
Income tax (benefit) expense	(14,190		)	(164		)	(10,116		)	—			(24,470		)
Equity of net income of subsidiaries	(44,412		)	—			—			44,412			—
Net income (loss)	$	(66,309	)	$	(253	)	$	(44,159	)	$	44,412		$	(66,309	)
Comprehensive income (loss)	$	(66,305	)	$	(253	)	$	(44,159	)	$	44,412		$	(66,305	)
2012:
Net sales	$	—		$	—		$	1,501,348		$	—		$	1,501,348
Cost of sales	—			—			1,130,053			—			1,130,053
Gross profit	—			—			371,295			—			371,295
Selling, general and administrative expenses	988			364			202,198			—			203,550
Provision for doubtful accounts	—			—			24,047			—			24,047
Settlement, litigation and other related charges	—			—			4,931			—			4,931
Other charges	—			—			5,036			—			5,036
Operating income (loss)	(988		)	(364		)	135,083			—			133,731
Interest expense, net of investment income	(37,625		)	—			(1,411		)	—			(39,036		)
Income (loss) before income taxes	(38,613		)	(364		)	133,672			—			94,695
Income tax (benefit) expense	(15,116		)	(142		)	48,528			—			33,270
Equity of net income of subsidiaries	84,922			—			—			(84,922		)	—
Net income (loss)	$	61,425		$	(222	)	$	85,144		$	(84,922	)	$	61,425
Comprehensive income (loss)	$	63,354		$	(222	)	$	87,071		$	(86,849	)	$	63,354

Note 9 - Guarantor Subsidiaries (Continued)

Summary Consolidating

Statements of Comprehensive Income (Loss)

(in thousands)



	For the nine months ended September 30,
2013:	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries			Consolidating / Eliminating Adjustments			Omnicare, Inc. and Subsidiaries
Net sales	$	—		$	—		$	4,675,901		$	—		$	4,675,901
Cost of sales	—			—			3,556,809			—			3,556,809
Gross profit	—			—			1,119,092			—			1,119,092
Selling, general and administrative expenses	3,696			1,233			595,967			—			600,896
Provision for doubtful accounts	—			—			74,749			—			74,749
Settlement, litigation and other related charges	—			—			169,615			—			169,615
Other charges	—			—			96,906			—			96,906
Operating income (loss)	(3,696		)	(1,233		)	181,855			—			176,926
Interest expense, net of investment income	(92,757		)	—			(1,248		)	—			(94,005		)
Income (loss) before income taxes	(96,453		)	(1,233		)	180,607			—			82,921
Income tax (benefit) expense	(37,395		)	(478		)	80,530			—			42,657
Equity of net income of subsidiaries	99,322			—			—			(99,322		)	—
Net income (loss)	$	40,264		$	(755	)	$	100,077		$	(99,322	)	$	40,264
Comprehensive income (loss)	$	40,170		$	(755	)	$	100,077		$	(99,322	)	$	40,170
2012:
Net sales	$	—		$	—		$	4,630,443		$	—		$	4,630,443
Cost of sales	—			—			3,523,702			—			3,523,702
Gross profit	—			—			1,106,741			—			1,106,741
Selling, general and administrative expenses	3,110			1,032			601,410			—			605,552
Provision for doubtful accounts	—			—			72,556			—			72,556
Settlement, litigation and other related charges	—			—			38,227			—			38,227
Other charges	35,092			—			30,665			—			65,757
Operating income (loss)	(38,202		)	(1,032		)	363,883			—			324,649
Interest expense, net of investment income	(103,146		)	—			(2,298		)	—			(105,444		)
Income (loss) before income taxes	(141,348		)	(1,032		)	361,585			—			219,205
Income tax (benefit) expense	(54,772		)	(400		)	138,521			—			83,349
Equity of net income of subsidiaries	222,432			—			—			(222,432		)	—
Net income (loss)	$	135,856		$	(632	)	$	223,064		$	(222,432	)	135,856
Comprehensive income (loss)	$	136,518		$	(632	)	$	224,448		$	(223,816	)	$	136,518

Note 9 - Guarantor Subsidiaries (Continued)

Condensed Consolidating Balance Sheets

(in thousands)



As of September 30, 2013:	Parent		Guarantor Subsidiary		Non-Guarantor Subsidiaries		Consolidating/Eliminating Adjustments			Omnicare, Inc. and Subsidiaries
ASSETS
Cash and cash equivalents	$	428,003	$	—	$	77,684	$	—		$	505,687
Restricted cash	—		—		5		—			5
Accounts receivable, net (including intercompany)	—		190		741,053		(190		)	741,053
Inventories	—		—		421,799		—			421,799
Deferred income tax benefits, net-current	—		—		98,089		—			98,089
Other current assets	2,683		—		309,543		—			312,226
Total current assets	430,686		190		1,648,173		(190		)	2,078,859
Properties and equipment, net	—		20		310,205		—			310,225
Goodwill	—		—		4,253,461		—			4,253,461
Identifiable intangible assets, net	—		—		166,105		—			166,105
Other noncurrent assets	47,654		20		59,202		—			106,876
Investment in subsidiaries	5,194,188		—		—		(5,194,188		)	—
Total assets	$	5,672,528	$	230	$	6,437,146	$	(5,194,378	)	$	6,915,526
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities	$	584,220	$	—	$	539,970	$	(190	)	$	1,124,000
Long-term debt, notes and convertible debentures	1,411,458		—		15,014		—			1,426,472
Deferred income tax liabilities	350,629		—		632,371		—			983,000
Other noncurrent liabilities	—		—		55,833		—			55,833
Stockholders' equity	3,326,221		230		5,193,958		(5,194,188		)	3,326,221
Total liabilities and stockholders' equity	$	5,672,528	$	230	$	6,437,146	$	(5,194,378	)	$	6,915,526
As of December 31, 2012:
ASSETS
Cash and cash equivalents	$	383,674	$	—	$	70,539	$	—		$	454,213
Restricted cash	—		—		1,066		—			1,066
Accounts receivable, net (including intercompany)	—		204		857,052		(204		)	857,052
Inventories	—		—		385,698		—			385,698
Deferred income tax benefits, net-current	—		—		137,736		(1,550		)	136,186
Other current assets	1,765		—		252,879		—			254,644
Total current assets	385,439		204		1,704,970		(1,754		)	2,088,859
Properties and equipment, net	—		22		282,638		—			282,660
Goodwill	—		—		4,256,959		—			4,256,959
Identifiable intangible assets, net	—		—		196,873		—			196,873
Other noncurrent assets	75,336		19		88,558		—			163,913
Investment in subsidiaries	5,453,702		—		—		(5,453,702		)	—
Total assets	$	5,914,477	$	245	$	6,529,998	$	(5,455,456	)	$	6,989,264
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities	$	60,454	$	54	$	421,710	$	(204	)	$	482,014
Long-term debt, notes and convertible debentures	2,012,807		—		17,223		—			2,030,030
Deferred income tax liabilities	335,504		—		580,706		(1,550		)	914,660
Other noncurrent liabilities	—		—		56,848		—			56,848
Stockholders' equity	3,505,712		191		5,453,511		(5,453,702		)	3,505,712
Total liabilities and stockholders' equity	$	5,914,477	$	245	$	6,529,998	$	(5,455,456	)	$	6,989,264

Note 9 - Guarantor Subsidiaries (Continued)

Condensed Consolidating Statements of Cash Flows - Unaudited

(in thousands)



	Nine months ended September 30,
2013:	Parent			Guarantor Subsidiary		Non-Guarantor Subsidiaries			Omnicare, Inc. and Subsidiaries
Cash flows from operating activities:
Net cash flows (used in) from operating activities	$	(42,519	)	$	—	$	497,184		$	454,665
Cash flows from investing activities:
Acquisition of businesses, net of cash received	—			—		(3,798		)	(3,798		)
Disposition of businesses	—			—		11,083			11,083
Capital expenditures	—			—		(74,127		)	(74,127		)
Other	(227		)	—		668			441
Net cash flows used in investing activities	(227		)	—		(66,174		)	(66,401		)
Cash flows from financing activities:
Payments on terms loans	(15,938		)	—		—			(15,938		)
Payments on long-term borrowings and obligations	(190,403		)	—		—			(190,403		)
Fees paid for financing activities	(4,851		)	—		—			(4,851		)
Decrease in cash overdraft balance	(10,232		)	—		(1,258		)	(11,490		)
Payments for Omnicare common stock repurchase	(91,259		)	—		—			(91,259		)
Dividends paid	(43,011		)	—		—			(43,011		)
Other	442,769			—		(422,607		)	20,162
Net cash flows from (used in) financing activities	87,075			—		(423,865		)	(336,790		)
Net increase in cash and cash equivalents	44,329			—		7,145			51,474
Cash and cash equivalents at beginning of period	383,674			—		70,539			454,213
Cash and cash equivalents at end of period	$	428,003		$	—	$	77,684		$	505,687
2012:
Cash flows from operating activities:
Net cash flows (used in) from operating activities	$	(43,685	)	$	—	$	460,588		$	416,903
Cash flows from investing activities:
Acquisition of businesses, net of cash received	—			—		(34,411		)	(34,411		)
Divestiture of business, net	—			—		19,207			19,207
Marketable securities	(25,000		)	—		—			(25,000		)
Capital expenditures	—			—		(71,433		)	(71,433		)
Other	—			—		1,348			1,348
Net cash flows used in investing activities	(25,000		)	—		(85,289		)	(110,289		)
Cash flows from financing activities:
Payments on term loans	(19,375		)	—		—			(19,375		)
Proceeds from long-term borrowings and obligations	425,000			—		—			425,000
Payments on long-term borrowings and obligations	(452,302		)	—		—			(452,302		)
Capped call transaction	(48,126		)	—		—			(48,126		)
Payments for Omnicare common stock repurchases	(110,919		)	—		—			(110,919		)
Dividends paid	(30,765		)	—		—			(30,765		)
Other	396,155			—		(399,136		)	(2,981		)
Net cash flows from (used in) financing activities	159,668			—		(399,136		)	(239,468		)
Net increase (decrease) in cash and cash equivalents	90,983			—		(23,837		)	67,146
Cash and cash equivalents at beginning of period	460,253			—		120,009			580,262
Cash and cash equivalents at end of period	$	551,236		$	—	$	96,172		$	647,408